Legis Daily

To provide for a Medicare demonstration project to evaluate the fiscal impact of covering low vision devices as durable medical equipment under part B of the Medicare program.

USA115th CongressHR-2050| House 
| Updated: 4/21/2017
Carolyn B. Maloney

Carolyn B. Maloney

Democratic Representative

New York

Cosponsors (9)
Tim Ryan (Democratic)Adam B. Schiff (Democratic)Stephanie N. Murphy (Democratic)Steve Cohen (Democratic)Gus M. Bilirakis (Republican)Stephen F. Lynch (Democratic)Seth Moulton (Democratic)John J. Duncan (Republican)Alcee L. Hastings (Democratic)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Medicare Demonstration of Coverage for Low Vision Devices Act of 2017 This bill requires the Centers for Medicare & Medicaid Services (CMS) to carry out a demonstration project to evaluate the fiscal impact of covering low-vision devices under Medicare in the same manner as Medicare coverage is provided for durable medical equipment. "Low-vision device" means a physician-prescribed device that magnifies, enhances, or otherwise augments or interprets visual images; the term does not include ordinary eyeglasses or contact lenses. The bill appropriates $2.5 million for FY2018 and each of the next four fiscal years for the CMS to carry out the project.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Apr 6, 2017
Introduced in House
Apr 6, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 6, 2017
Sponsor introductory remarks on measure. (CR E475)
Apr 7, 2017
Referred to the Subcommittee on Health.
Apr 21, 2017
Referred to the Subcommittee on Health.
  • April 6, 2017
    Introduced in House


  • April 6, 2017
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • April 6, 2017
    Sponsor introductory remarks on measure. (CR E475)


  • April 7, 2017
    Referred to the Subcommittee on Health.


  • April 21, 2017
    Referred to the Subcommittee on Health.

Health

Congressional oversightGovernment studies and investigationsHealth care coverage and accessHealth technology, devices, suppliesHearing, speech, and vision careMedicare

To provide for a Medicare demonstration project to evaluate the fiscal impact of covering low vision devices as durable medical equipment under part B of the Medicare program.

USA115th CongressHR-2050| House 
| Updated: 4/21/2017
Medicare Demonstration of Coverage for Low Vision Devices Act of 2017 This bill requires the Centers for Medicare & Medicaid Services (CMS) to carry out a demonstration project to evaluate the fiscal impact of covering low-vision devices under Medicare in the same manner as Medicare coverage is provided for durable medical equipment. "Low-vision device" means a physician-prescribed device that magnifies, enhances, or otherwise augments or interprets visual images; the term does not include ordinary eyeglasses or contact lenses. The bill appropriates $2.5 million for FY2018 and each of the next four fiscal years for the CMS to carry out the project.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Apr 6, 2017
Introduced in House
Apr 6, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 6, 2017
Sponsor introductory remarks on measure. (CR E475)
Apr 7, 2017
Referred to the Subcommittee on Health.
Apr 21, 2017
Referred to the Subcommittee on Health.
  • April 6, 2017
    Introduced in House


  • April 6, 2017
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • April 6, 2017
    Sponsor introductory remarks on measure. (CR E475)


  • April 7, 2017
    Referred to the Subcommittee on Health.


  • April 21, 2017
    Referred to the Subcommittee on Health.
Carolyn B. Maloney

Carolyn B. Maloney

Democratic Representative

New York

Cosponsors (9)
Tim Ryan (Democratic)Adam B. Schiff (Democratic)Stephanie N. Murphy (Democratic)Steve Cohen (Democratic)Gus M. Bilirakis (Republican)Stephen F. Lynch (Democratic)Seth Moulton (Democratic)John J. Duncan (Republican)Alcee L. Hastings (Democratic)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Congressional oversightGovernment studies and investigationsHealth care coverage and accessHealth technology, devices, suppliesHearing, speech, and vision careMedicare